## TRMB: Trimble Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_10 0.5% below STRENGTH zone (3.0-6.0%); PEG 2.30 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($78.01)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Keybanc | $99 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Keybanc | up | Overweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 1 ($0.00M) |
| Sells | 9 ($2.29M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.5% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.7% (+0.6%)
- Blackrock Inc.: 8.2% (-5.4%)
- Morgan Stanley: 5.4% (-4.5%)
- State Street Corpora: 4.6% (+0.4%)
- Generation Investmen: 3.5% (-7.3%)

### Key Risks

1. Market regime shift could impact high-beta names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.30 elevated, pricing in significant growth expectations. Forward P/E 23.7x stretched relative to 12% growth. Insider selling cluster ($2.3M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $19.5B |
| Beta | 1.60 |
| 52W Range | $52.91 - $87.50 |
| Short Interest | 2.4% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.30 |
| Forward P/E | 23.7 |
| Current P/E | 26.5 |
| YoY Growth | 11.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 improving modestly (+0.7% over 5 days). Below STRENGTH zone by 2.5pp (needs >3.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. Full SMA alignment bullish (above 20/50/200 SMAs). RSI neutral at 55. OFD pattern: +MTL (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.48% (CS: 60) | Neutral |
| RSI_14 | 55.3 | Neutral |
| MACD Histogram | -0.12 | Bearish |
| vs SMA20 | 1.008x | Above |
| vs SMA50 | 1.028x | Above |
| vs SMA200 | 1.085x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $81.95
- **Stop Loss:** $78.01 (4.8% risk)
- **Target:** $85.89 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 304
- **Position Value:** $24,912.80
- **Portfolio %:** 24.91%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 120% | L2 100% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.20x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with improving risk appetite. VIX decline to 52-week lows and moderate breadth recovery suggest calming conditions, though narrow participation indicates selectivity remains key. Positive earnings momentum and AI adoption themes provide fundamental support for quality growth names.*

### Earnings

**Next:** 2026-02-18 (Est: $0.96)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.72 | $0.81 | +13.0% |
| 2025Q2 | $0.62 | $0.71 | +13.6% |
| 2025Q1 | $0.58 | $0.61 | +4.4% |
| 2024Q4 | $0.88 | $0.89 | +0.6% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*